Psychedelics
Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial
Hi, what are you looking for?
Mugglehead Investment Magazine
z
Sleep
In Q4, ResMed's revenue enjoyed a 4 per cent bump to $914.7 million, an 8 per cent increase over the previous year.
Canada
Rise & Shine CBD Drops will initially be available in British Columbia followed by national distribution this fall
Technology
The report showcases the company's efforts to reduce its environmental footprint, while cultivating social responsibility and operating with strong governance.
Sleep
Texas technology company announces US$60M in funding and waitlist for new wearable smart product
Research
The improvements were sustained for at least one month after the experiment
Technology
The approval is the final hurdle that Lumen and Brightspeed had to cross for the transaction to close
Cannabis
Monitoring the Future panel study supported by the NIH outlines new statistics
Health & Wellness
Wojcicki will feature on a spotlight session called “Disruption Ahead” wherein she will speak about putting the consumer at the centre of healthcare.
International
New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions
AI and Autonomy
